BlackRock’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.5M | Sell |
|
|||||
|
2025
Q1 | $28.4M | Buy |
|
|||||
|
2024
Q4 | $43.2M | Buy |
|
|||||
|
2024
Q3 | $153M | Buy |
|
|||||
|
2024
Q2 | $115M | Buy |
|
|||||
|
2024
Q1 | $143M | Buy |
|
|||||
|
2023
Q4 | $81M | Buy |
|
|||||
|
2023
Q3 | $59.5M | Buy |
|
|||||
|
2023
Q2 | $70.1M | Buy |
|
|||||
|
2023
Q1 | $71.6M | Buy |
|
|||||
|
2022
Q4 | $78.7M | Buy |
|
|||||
|
2022
Q3 | $55M | Buy |
|
|||||
|
2022
Q2 | $38.6M | Buy |
|
|||||
|
2022
Q1 | $70.6M | Buy |
|
|||||
|
2021
Q4 | $75.3M | Buy |
|
|||||
|
2021
Q3 | $48.8M | Sell |
|
|||||
|
2021
Q2 | $52.6M | Buy |
|
|||||
|
2021
Q1 | $75.3M | Buy |
|
|||||
|
2020
Q4 | $84.6M | Buy |
|
|||||
|
2020
Q3 | $25.2M | Sell |
|
|||||
|
2020
Q2 | $24.8M | Buy |
|